Nathan J. Dowden is COO at Entrada Therapeutics, Inc. (TRDA). They have made 5 open-market trades across 1 company since 2022, most recently 2026-09-02.
CIK 0001873392
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TRDA | 196,060 | $857K |
Shares reported on the most recent Form 4, priced at the 2026-09-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TRDA | SELL · 10b5-1 | 2026-05-04 | 2026-05-04 | $15.33 | $230K | -57.0% | -58.6% | -54.3% |
| TRDA | SELL | 2026-03-09 | 2026-03-11 | $13.04 | $196K | -14.4% | +0.6% | -52.6% |
| TRDA | SELL · 10b5-1 | 2024-09-26 | 2024-09-30 | $16.00 | $14K | -0.6% | +8.3% | +9.2% |
| TRDA | SELL · 10b5-1 | 2024-09-06 | 2024-09-10 | $15.09 | $35K | -0.3% | +7.4% | +46.2% |
| TRDA | SELL · 10b5-1 | 2024-08-16 | 2024-08-20 | $16.26 | $873K | +4.5% | -11.4% | +3.1% |
| TRDA | SELL · 10b5-1 | 2024-03-06 | 2024-03-08 | $12.32 | $22K | +5.1% | +5.9% | +24.4% |
| TRDA | SELL · 10b5-1 | 2023-09-06 | 2023-09-06 | $13.47 | $13K | +2.9% | +6.7% | +0.9% |
| TRDA | SELL · 10b5-1 | 2023-07-10 | 2023-07-12 | $18.04 | $198K | +6.9% | +3.5% | -1.5% |
| TRDA | SELL · 10b5-1 | 2023-06-20 | 2023-06-22 | $15.42 | $493K | +5.2% | +9.2% | -8.5% |
| TRDA | SELL | 2022-10-31 | 2022-11-02 | $24.05 | $51K | -14.1% | -16.5% | -44.6% |
| TRDA | SELL | 2022-10-25 | 2022-10-27 | $20.72 | $369K | -11.7% | -35.2% | -36.2% |
| TRDA | SELL | 2022-10-20 | 2022-10-24 | $18.54 | $164K | +5.0% | -30.4% | -32.8% |
| TRDA | SELL · 10b5-1 | 2022-09-26 | 2022-09-28 | $15.45 | $24K | -6.4% | +44.7% | -3.7% |
| TRDA | SELL · 10b5-1 | 2022-09-21 | 2022-09-23 | $15.12 | $65K | -11.3% | +24.6% | -2.7% |
| TRDA | SELL · 10b5-1 | 2022-09-15 | 2022-09-19 | $15.01 | $2K | +16.0% | +28.7% | +48.4% |
| TRDA | SELL · 10b5-1 | 2022-09-08 | 2022-09-12 | $15.11 | $27K | +9.3% | +18.1% | +32.1% |
| TRDA | SELL | 2022-06-27 | 2022-06-29 | $13.00 | $100K | -12.0% | +2.4% | +21.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.